NGVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ingevity Corp (NGVT) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant declines in revenue, net income, and EPS in the latest quarter. Additionally, there are no strong positive catalysts or trading signals to support a buy decision. The stock's technical indicators are neutral to slightly bullish, but this is not enough to outweigh the negative financial and sentiment factors.
The technical indicators show mixed signals. The MACD histogram is slightly positive at 0.00973, indicating mild bullish momentum. RSI is neutral at 61.398, and moving averages are bullish with SMA_5 > SMA_20 > SMA_200. Key support and resistance levels are Pivot: 75.147, R1: 76.685, S1: 73.609, R2: 77.634, S2: 72.66. However, these signals are not strong enough to suggest a clear buy opportunity.
No significant positive catalysts identified. Technical indicators are slightly bullish, but no major trading signals or news events are driving the stock.
Analysts have a neutral stance, and there is uncertainty due to the sale of the Industrial Specialties business and exploration of alternatives for other businesses. No recent news or significant insider/hedge fund activity to support a buy.
In Q4 2025, revenue dropped to $255.1M (-3.11% YoY), net income fell to -$84.6M (-609.64% YoY), and EPS declined to -2.37 (-615.22% YoY). Gross margin also decreased to 34.42% (-9.28% YoY), indicating deteriorating profitability.
Wells Fargo recently raised the price target to $65 from $60 but maintained an Equal Weight rating. Analysts remain neutral due to uncertainty surrounding the company's business restructuring and lack of clear growth drivers.
